T. Rowe Price Health Sciences Fund (PRHSX)

Access innovative companies in a dynamic industry.

Call 866-349-5897 to speak to an investment specialist about the
Health Sciences Fund.

Ticker Symbol:
Fund Status:
Open to new Retail investors  /  Open to subsequent Retail investments
Fund Composition
Asset Allocation
as of 09/30/2017
Volatility and Other Measures
as of 09/30/2017
Beta 1.03
Standard Deviation 15.90
Price/Earnings Ratio (Domestic) 21.1
Earnings Growth Rate (Domestic) 11.4
Turnover Rate 26.7
Median Market
$38,332.15 Million
Sector Diversification
as of 09/30/2017
% of Total Net Assets
Biotechnology 36.5%
Services 24.4%
Pharmaceuticals 16.7%
Products & Devices 15.3%
Life Sciences 6.8%
Miscellaneous 0.1%
10 Largest Holdings
Represents 30.83 % of Total Net Assets
View Holdings as of:
Agilent Technologies
Alexion Pharmaceuticals
Becton, Dickinson & Company
Intuitive Surgical
Puma Biotechnology
UnitedHealth Group
Vertex Pharmaceuticals
As of 09/30/2017 the Health Sciences Fund had a total of 163 holdings.
See Glossary for additional details on all data elements.